CVS TO PAY $315M TO SETTLE OPIOID PRESCRIPTION ALLEGATIONS
By VA Headlines · Published Nov 3, 2026 · Source dated October 13, 2026 (U.S. Department of Justice)
CVS Pharmacy Inc. and related companies have agreed to pay $315 million to resolve allegations that, from October 17, 2013, through December 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances and then billed Medicare and other federal health care programs for many of them, the Justice Department announced October 13, 2026. The Department of Veterans Affairs was among the agencies that assisted.
This is a settlement, not a finding. DOJ says the claims resolved by the settlement are allegations only and there has been no determination of liability.
What the government alleged
The United States filed its complaint on December 13, 2024, in federal court in Rhode Island. According to DOJ, the government alleged that CVS:
Filled prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, or were not issued in the usual course of professional practice.
Dispensed dangerous and excessive quantities of opioids, filled opioid prescriptions too early, and filled "trinity" prescriptions, a combination of an opioid, a benzodiazepine and a muscle relaxant that DOJ calls dangerous and abused.
Filled prescriptions from "pill mill" prescribers, despite clear red flags.
Did this because of corporate performance metrics, incentive pay and staffing policies that, the complaint alleged, put profits over patient safety. DOJ says CVS policies also allegedly kept pharmacists from warning one another about certain problem prescribers.
DOJ says many of these prescriptions were billed to and paid by federal health care programs, which is where the False Claims Act comes in.
A whistleblower case
The settlement resolves a lawsuit filed by a former CVS employee under the False Claims Act's whistleblower provision, which lets private parties sue on behalf of the United States and receive a share of any recovery. The government intervened and took over the case. DOJ says the whistleblower's share has not yet been determined.
What CVS agreed to do next
Besides the payment, CVS signed a memorandum of agreement with the Drug Enforcement Administration. DOJ says it requires CVS to:
Set up a hotline for employees and the public to report suspected illegal dispensing of controlled substances.
Proactively monitor its pharmacies' dispensing patterns.
Set up a process to evaluate prescribers suspected of illegal prescribing.
The VA connection
DEA's Office of Diversion Control led the case, DOJ says, with substantial assistance from HHS OIG, the Defense Criminal Investigative Service, the Defense Health Agency, the Office of Personnel Management, the Labor Department's OIG, and the Department of Veterans Affairs. Federal health programs that serve veterans, service members and their families depend on pharmacies dispensing controlled substances only when they are medically appropriate.
Related: VA fraud cases tracker. Oklahoma medical supply owner gets 14 years for $30M Medicare, TRICARE and CHAMPVA fraud. SpineFrontier kickbacks: surgeon and distributor sentenced. More: all VA Headlines reports. How we report: Methodology & Corrections.
CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government · October 13, 2026
Read the DOJ release
This is a civil settlement. Per DOJ, the claims resolved by the settlement are allegations only and there has been no determination of liability. VA Headlines reports only what official records say. Spot an error? See our corrections policy.